Leukemia

The Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital is comprised of an internationally recognized team of physicians and scientists who specialize in the treatment of acute and chronic leukemias including, but not limited to, acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), and bone marrow failure diseases such as aplastic anemia, paroxysmal nocturnal hemoglobinuria, large granular lymphocytic leukemia, and others.

Led by Gail J. Roboz, MD, our team is at the forefront of breakthrough biomedical and clinical research in leukemia. We have participated in the development of all major drugs recently approved by the United States Food and Drug Administration (FDA) for patients with leukemia. Patients in our Program have access to a robust clinical trials portfolio that includes studies for newly diagnosed, as well as relapsed/refractory adult patients.

Every second counts in the fight against leukemia, a disease that can manifest in highly aggressive and fast-growing forms. As part of our dedication to addressing treatment needs as quickly as possible, our team of experts is available for same-day appointments for newly diagnosed leukemia patients. To schedule a visit, please call (646) 962-2700.